ArticlePloS one2008

Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice.

Maria A Croyle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.